Trace Amine-Associated Receptor 1 (TAAR1): A Potential New Target For The Treatment of Schizophrenia
Speaker Christoph Correll, MD is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)Speaker Jehan Marino, PharmD, BCPP is an employee for Otsuka Pharmaceutical Development & Commercialization, Inc. […]